Shares of GSK PLC GSK slid 2.42% to £14.34 Wednesday, on what proved to be an all-around dismal trading session for the stock ...

The drug industry is lobbying for potential tariffs to be implemented gradually instead of immediately being imposed at a 25% ...

The findings add to a growing body of evidence that the shingles vaccine may help keep dementia at bay – but researchers ...

Patients in the pembrolizumab-olaparib arm had clinically meaningful improvements in PFS over patients in the control arm.

If you were a 23andMe customer, your genetic and personal information could be used in civil or criminal cases, targeted ...

Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has ...

The most common causes of chronic cough include gastroesophageal reflux disease (GERD), asthma, and postnasal drip (also ...

UK shares declined as global markets anticipated U.S. President Trump's announcement on reciprocal tariffs, sparking trade ...

European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

Shares of GSK plc (LON:GSK – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. One research ...

Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis.

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...